|
1
|
Ahmed WA, Ali-Din NH, Yoshioka M and
EL-Merzabani M: 2′-Deoxycytidine (DCYD) as a potential biological
marker for detecting acute lymphocytic leukemia and bladder cancer.
J Union Arab Biol Cairo. 20A:97–111. 2003.
|
|
2
|
Ahmed WA, Moneer M, Abo-Shady MM, Mansour
HH, Abd-El-Wahab N, Yoshioka M and EL-Merzabani M: 2′-Deoxycytidine
as a potential biomarker for detection of hepatocellular carcinoma.
Egyptian J Hosp Med. 21:191–201. 2005.
|
|
3
|
Yoshioka M, Abu-Zeid M, Kubo T and
El-Merzabani M: Identification of a previously unknown compound as
2′-deoxycytidine found in the plasma of breast cancer patients
under combined chemotherapy. Biol Pharm Bull. 17:169–174. 1994.
|
|
4
|
Iwazaki A and Yoshioka M: 2′-Deoxycytidine
decreases the anti-tumor effects of 5-fluorouracil on mouse myeloma
cells. Biol Pharm Bull. 33:1024–1027. 2010.
|
|
5
|
Moyer JD, Malinowski N and Ayers O:
Salvage of circulating pyrimidine nucleosides by tissues of the
mouse. J Biol Chem. 260:2812–2818. 1985.PubMed/NCBI
|
|
6
|
Rossi L, Serafini S, Schiavano GF,
Casabianca A, Vallanti G, Chiarantini L and Magnani M: Metabolism,
mitochondrial uptake and toxicity of 2′, 3′-dideoxycytidine.
Biochem J. 344:915–920. 1999.
|
|
7
|
Berlinger WG, Stene RA, Spector R and
Al-Jurf AS: Plasma and cerebrospinal fluid nucleosides and
oxypurines in acute liver failure. J Lab Clin Med. 110:137–144.
1987.PubMed/NCBI
|
|
8
|
Schneider WC and Behki RM: Phosphorus
compounds in animal tissues. VII Enzymatic formation of
deoxycytidine diphosphate choline and lecithin by tissue
homogenates. J Biol Chem. 238:3565–3571. 1963.
|
|
9
|
Osogoe B and Ueki A: A radioautographic
study of the utilization of deoxycytidine for the formation of
deoxyribonucleic acid-thymine in lymphocytes. J Cell Biol.
46:403–405. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osogoe B, Tyler RW and Everett NB: The
patterns of labeling of germinal-center cells with tritiated
deoxycytidine. J Cell Biol. 57:215–220. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muramatsu M, Kinoshita K, Fagarasan S,
Yamada S, Shinkai Y and Honjo T: Class switch recombination and
hypermutation require activation-induced cytidine deaminase (AID),
a potential RNA editing enzyme. Cell. 102:553–563. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muramatsu M, Sankaranand VS, Anant S,
Sugai M, Kinoshita K, Davidson NO and Honjo T: Specific expression
of activation-induced cytidine deaminase (AID), a novel member of
the RNA-editing deaminase family in germinal center B cells. J Biol
Cell. 274:18470–18476. 1999.
|
|
13
|
Kotani A, Okazaki I, Muramatsu M,
Kinoshita K, Begum NA, Nakajima T, Saito H and Honjo T: A target
selection of somatic hypermutations is regulated similarly between
T and B cells upon activation-induced cytidine deaminase
expression. Proc Natl Acad Sci USA. 102:4506–4511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harris RS, Petersen-Mahrt SK and Neuberger
MS: RNA editing enzyme APOBEC1 and some of its homologs can act as
DNA mutators. Mol Cell. 10:1247–1253. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okazaki IM, Hiai H, Kakazu N, Yamada S,
Muramatsu M, Kinoshita K and Honjo T: Constitutive expression of
AID leads to tumorigenesis. J Exp Med. 197:1173–1118. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan TS, Lakhchaura BD and Hsu TF:
Differences in deoxycytidine metabolism in mouse and rat. Biochem
J. 210:367–371. 1983.PubMed/NCBI
|
|
17
|
Miwa M, Eda H, Ura M, Ouchi KF, Keith DD,
Foley LH and Ishitsuka H: High susceptibility of human cancer
xenografts with higher levels of cytidine deaminase to a
2′-deoxycytidine antimetabolite, 2′-deoxy-2′-methylidenecytidine.
Clin Cancer Res. 4:493–497. 1998.PubMed/NCBI
|
|
18
|
Chen EH, Johnson EE II, Vetter SM and
Mitchell BS: Characterization of the deoxycytidine kinase promoter
in human lymphoblast cell lines. J Clin Invest. 95:1660–1668. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hapke DM, Stegmann AP and Mitchell BS:
Retroviral transfer of deoxycytidine kinase into tumor cell lines
enhances nucleoside toxicity. Cancer Res. 56:2343–2347.
1996.PubMed/NCBI
|
